These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24630077)

  • 1. Making change happen: a case study of the successful establishment of a peer-administered naloxone program in one Australian jurisdiction.
    Lancaster K; Ritter A
    Int J Drug Policy; 2014 Sep; 25(5):985-91. PubMed ID: 24630077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
    Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
    Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Naloxone works': The politics of knowledge in 'evidence-based' drug policy.
    Lancaster K; Treloar C; Ritter A
    Health (London); 2017 May; 21(3):278-294. PubMed ID: 28135864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
    Lipworth W; Doran E; Kerridge I; Day R
    Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network structures and their relevance to the policy cycle: a case study of The National Male Health Policy of Australia.
    Holden CA; Lin V
    Soc Sci Med; 2012 Jan; 74(2):228-35. PubMed ID: 22155009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intergovernmental health policy decisions in Brazil: cooperation strategies for political mediation.
    Miranda AS
    Health Policy Plan; 2007 May; 22(3):186-92. PubMed ID: 17485420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
    Hughes CE
    Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Australia's National Medicines Policy using geographical mapping.
    Roughead EE; Monteith GR; Harvey KJ; Tett SE
    Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intelligent policy making? Key actors' perspectives on the development and implementation of an early years' initiative in Scotland's public health arena.
    Deas L; Mattu L; Gnich W
    Soc Sci Med; 2013 Nov; 96():1-8. PubMed ID: 24034945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010.
    Lancaster K; Ritter A
    Int J Drug Policy; 2014 Jan; 25(1):81-7. PubMed ID: 23931957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
    Hughes CE
    Drug Alcohol Rev; 2007 Jul; 26(4):363-8. PubMed ID: 17564871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.
    Ritter A; Bammer G; Hamilton M; Mazerolle L;
    Drug Alcohol Rev; 2007 May; 26(3):265-71. PubMed ID: 17454015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the process of establishing a food and nutrition policy: the case of Slovenia.
    Kugelberg S; Jönsson K; Yngve A
    Health Policy; 2012 Sep; 107(1):91-7. PubMed ID: 22771079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New norms new policies: Did the Adelaide Thinkers in Residence scheme encourage new thinking about promoting well-being and Health in All Policies?
    Baum F; Lawless A; MacDougall C; Delany T; McDermott D; Harris E; Williams C
    Soc Sci Med; 2015 Dec; 147():1-9. PubMed ID: 26520058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
    Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
    Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusive research: making a difference to policy and legislation.
    Johnson K; Minogue G; Hopklins R
    J Appl Res Intellect Disabil; 2014 Jan; 27(1):76-84. PubMed ID: 24259396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A policy case study of blood in Australia.
    Graves N; Clare G; Haines M; Bird R
    Soc Sci Med; 2010 Nov; 71(9):1677-82. PubMed ID: 20843593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tale of CIN--the Cannabis infringement notice scheme in Western Australia.
    Lenton S; Allsop S
    Addiction; 2010 May; 105(5):808-16. PubMed ID: 20331566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Mid-Level Policy Analysis to Macro-Level Political Economy Comment on "Developing a Framework for a Program Theory-Based Approach to Evaluating Policy Processes and Outcomes: Health in All Policies in South Australia".
    Labonté R
    Int J Health Policy Manag; 2018 Jul; 7(7):656-658. PubMed ID: 29996585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.